Home
Gulbenkian Institute for Molecular Me...

Gulbenkian Institute for... Market Share Analysis for June 2026

"The GIMM Foundation is the result of a visionary merger between two renowned scientific research institutions in Portugal: the Instituto Gulbenkian de Ciência (IGC) and the Instituto de Medicina Molecular João Lobo Antunes (iMM). This union... Mais

Science and Education > Biology

Domaingimm.pt

Year Founded2004

Employees501 - 1000

Annual Revenue--

Gulbenkian Institute for Molecular Me...

Gulbenkian Institute for Molecular Me... (including company regionals)

gimm.pt

See more website traffic and engagement information

Total visits to Gulbenkian Institute for Molecular Me...'s top domains

Understand Gulbenkian Institute for Molecular Me... market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gimm.pt25.8K

See more with Sales Intelligence

Avg. visit duration in Gulbenkian Institute for Molecular Me...'s top domains

Analyze Gulbenkian Institute for Molecular Me... engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gimm.pt00:00:27

See more with Sales Intelligence

Avg. pageviews on Gulbenkian Institute for Molecular Me...'s top domains

See how Gulbenkian Institute for Molecular Me... keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gimm.pt2.41

See more with Sales Intelligence

Gulbenkian Institute for Molecular Me... top competitors by domain

Top similar sites in June 2026, ranked by their affinity

astrazeneca.ptCompany NameAstraZenecaEmployees> 10001HQUnited Kingdom, CambridgeAnnual revenue> $1BTotal visits1.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Gulbenkian Institute for Molecular Me...

These are the website technologies, by industry, used by Gulbenkian Institute for Molecular Me... top domains

Payment & Currencies (11)

Cart Functionality

eCommerce (5)

Swap

Widget (4)

Twemoji

Cryptocurrency (3)

Bitcoin Acceptance

More Technologies

11

See all

News & Signals from Gulbenkian Institute for Molecular Me...

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMicroviable Therapeutics SL partners with GIMM Foundation.* Microviable Therapeutics SL is excited to work together with Fundaçao GIMM- Gulbenkian Institute for Molecular Medicine to carry out a preclinical model of CRC using MVT-201 as adjuvant for anti-PD1 immunotherapy.

NewsGIMM Foundation signs new client European Space Agency.ESA selects GIMM to host Europe's first space-linked biobank.

NewsGIMM Foundation attends event 12th EU-LIFE Community Meeting.From 21 to 23 May, 7 "GIMMers" from the Gulbenkian Institute for Molecular Medicine (GIMM) headed to Brno, Czech Republic to take part in the 12th EU-LIFE Community Meeting, this year expertly hosted by CEITEC - Central European Institute of Technology.